BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 7475485)

  • 1. [Strategies for universal vaccination against hepatitis B].
    Pérez-Trallero E; Cilla G
    Med Clin (Barc); 1995 Sep; 105(8):316. PubMed ID: 7475485
    [No Abstract]   [Full Text] [Related]  

  • 2. Model based analysis of hepatitis B vaccination strategies in the Netherlands.
    Kretzschmar M; Mangen MJ; van de Laar M; de Wit A
    Vaccine; 2009 Feb; 27(8):1254-60. PubMed ID: 19118594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroepidemiology of hepatitis B in Greek children 6 years after the implementation of universal vaccination.
    Papaevangelou V; Hadjichristodoulou C; Cassimos DC; Pantelaki K; Tzivaras A; Hatzimichael A; Theodoridou M
    Infection; 2008 Mar; 36(2):135-9. PubMed ID: 18231718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two decades of universal hepatitis B vaccination in taiwan: impact and implication for future strategies.
    Ni YH; Huang LM; Chang MH; Yen CJ; Lu CY; You SL; Kao JH; Lin YC; Chen HL; Hsu HY; Chen DS
    Gastroenterology; 2007 Apr; 132(4):1287-93. PubMed ID: 17433322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-term efficacy of infant hepatitis B immunization program].
    Gong J; Li RC; Yang JY; Li YP; Chen XR; Xu ZY; Liu CB; Cao HL; Zhao K; Ni DM
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):203-5. PubMed ID: 12716514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of a new universal infant and school-based adolescent hepatitis B vaccination program in Australia.
    Gidding HF; Warlow M; MacIntyre CR; Backhouse J; Gilbert GL; Quinn HE; McIntyre PB
    Vaccine; 2007 Dec; 25(51):8637-41. PubMed ID: 18054127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vaccination against hepatitis B. The 1988-1991 experience at Local Health District 9, Lombardy].
    Gariboldi G
    Ann Ig; 1993; 5(3):199-205. PubMed ID: 7513177
    [No Abstract]   [Full Text] [Related]  

  • 8. Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: an experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence.
    Hung HF; Chen TH
    Vaccine; 2009 Nov; 27(48):6770-6. PubMed ID: 19735755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hepatitis B vaccination is still current].
    Kremp O
    Soins Pediatr Pueric; 1999; (187):31-2. PubMed ID: 10615148
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum level of anti-hepatitis B surface antigen 6-8 years after hepatitis B vaccination at birth.
    Kazemi A; Koosha A; Rafizadeh B; Mousavinasab N; Mahram M
    East Mediterr Health J; 2008; 14(4):960-5. PubMed ID: 19166180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B in Canada: the case for universal vaccination. Infectious Diseases and Immunization Committee, Canadian Paediatric Society.
    CMAJ; 1992 Jan; 146(1):25-8. PubMed ID: 1530816
    [No Abstract]   [Full Text] [Related]  

  • 12. Global progress toward universal childhood hepatitis B vaccination, 2003.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2003 Sep; 52(36):868-70. PubMed ID: 12970620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-HBs profiles in children treated for neoplastic disease who had been vaccinated against hepatitis B postnatally or as infants.
    Koltan S; Koltan A; Wysocki M; Debski R; Styczynski J
    J Hosp Infect; 2005 May; 60(1):73-7. PubMed ID: 15823661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Epidemiological effect of hepatitis B immunization among newborn babies in Beijing].
    Gong XH; Liu LR; Jia L; Li YH; Xing YL; Wang QY
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):201-2. PubMed ID: 12716513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunoprophylaxis against hepatitis B].
    Mayoral Cortés JM; Fernández de la Mota E
    Med Clin (Barc); 1992 Nov; 99(16):624-6. PubMed ID: 1460928
    [No Abstract]   [Full Text] [Related]  

  • 16. A success story: universal vaccination in Italy--what has to be done to eradicate residual acute hepatitis B?
    Gervais A; Longuet P; Leport C
    Clin Infect Dis; 2008 Mar; 46(6):876-7. PubMed ID: 18269331
    [No Abstract]   [Full Text] [Related]  

  • 17. The underestimated risk of hepatitis A and hepatitis B: benefits of an accelerated vaccination schedule.
    Keystone JS; Hershey JH
    Int J Infect Dis; 2008 Jan; 12(1):3-11. PubMed ID: 17643334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Control of hepatitis B in French Polynesia with a program of systematic vaccination of newborns with the Genhevac B vaccine].
    Moulia-Pelat JP; Spiegel A; Excler JL; Martin P; Roux JF; Boutin JP; Blondeau C; Saliou P
    Sante; 1996; 6(1):11-5. PubMed ID: 8612008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges.
    Mele A; Tosti ME; Mariano A; Pizzuti R; Ferro A; Borrini B; Zotti C; Lopalco P; Curtale F; Balocchini E; Spada E;
    Clin Infect Dis; 2008 Mar; 46(6):868-75. PubMed ID: 18269332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence of Hepatitis-B infection amongst Taiwanese university students 18 years following the commencement of a national Hepatitis-B vaccination program.
    Su FH; Chen JD; Cheng SH; Lin CH; Liu YH; Chu FY
    J Med Virol; 2007 Feb; 79(2):138-43. PubMed ID: 17177303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.